WG
IOVA icon

Winton Group’s Iovance Biotherapeutics IOVA Stock Holding History

Winton Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
+337,657
New +$1.08M 0.04% 497
2023
Q2 		– Sell
-18,929
Closed -$116K – 934
2023
Q1 		$116K Buy
18,929
+208
+1% +$1.44K 0.01% 926
2022
Q4 		$120K Buy
18,721
+879
+5% +$6.86K 0.01% 882
2022
Q3 		$171K Buy
+17,842
New +$206K 0.01% 884
2022
Q2 		– Sell
-16,190
Closed -$270K – 1008
2022
Q1 		$270K Buy
16,190
+3,089
+24% +$47.8K 0.01% 842
2021
Q4 		$250K Buy
+13,101
New +$288K 0.02% 885
2021
Q1 		– Sell
-15,264
Closed -$708K – 1409
2020
Q4 		$708K Sell
15,264
-3,101
-17% -$123K 0.05% 603
2020
Q3 		$605K Buy
+18,365
New +$563K 0.02% 1032

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return